{"id":"https://openalex.org/W7225199932","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0083","title":"83 Translational PBPK modeling of PET imaging reveals enhanced predicted tumor exposure of antiCTLA4 singledomain antibody fragments vs. monoclonal antibodies","display_name":"83 Translational PBPK modeling of PET imaging reveals enhanced predicted tumor exposure of antiCTLA4 singledomain antibody fragments vs. monoclonal antibodies","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225199932","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0083"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0083","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0083","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0083","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A91.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A91.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019927985","display_name":"Daniel J. Rubins","orcid":"https://orcid.org/0000-0002-1587-6190","observed_orcids":["https://orcid.org/0000-0002-1587-6190"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J Rubins","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160483074","display_name":"Tommy Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tommy Li","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054158601","display_name":"Kerry A. Riffel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kerry A Riffel","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027205093","display_name":"Hyking Haley","orcid":"https://orcid.org/0000-0001-6705-2276","observed_orcids":["https://orcid.org/0000-0001-6705-2276"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hyking Haley","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120963841","display_name":"Xiangjun Meng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiangjun Meng","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054064237","display_name":"Mona L. Purcell","orcid":"https://orcid.org/0000-0002-1339-3611","observed_orcids":["https://orcid.org/0000-0002-1339-3611"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mona Purcell","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160549147","display_name":"Krista Getty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Krista Getty","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112147488","display_name":"Edward P. Bowman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward Bowman","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087373628","display_name":"Liza T. Gantert","orcid":"https://orcid.org/0000-0002-5042-8932","observed_orcids":["https://orcid.org/0000-0002-5042-8932"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liza Gantert","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055746516","display_name":"Kapil Mayawala","orcid":"https://orcid.org/0000-0001-7959-4881","observed_orcids":["https://orcid.org/0000-0001-7959-4881"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kapil Mayawala","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076595940","display_name":"Dinesh P. de Alwis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dinesh P de Alwis","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160556878","display_name":"Julie P Stone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie P Stone","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160391685","display_name":"Tapan Nayak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tapan Nayak","raw_affiliation_strings":["Merck, West Point, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, West Point, PA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A91","last_page":"A91"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.5576000213623047,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.5576000213623047,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.3955000042915344,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.017999999225139618,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/single-domain-antibody-fragments","display_name":"single-domain antibody fragments","score":0.6840000152587891},{"id":"https://openalex.org/keywords/vhh","display_name":"VHH","score":0.8479999899864197},{"id":"https://openalex.org/keywords/anti-ctla-4-antibody","display_name":"anti-CTLA-4 antibody","score":0.8479999899864197},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.7979999780654907},{"id":"https://openalex.org/keywords/tumor-penetration","display_name":"tumor penetration","score":0.7250000238418579},{"id":"https://openalex.org/keywords/tumor-exposure","display_name":"tumor exposure","score":0.5419999957084656},{"id":"https://openalex.org/keywords/physiologically-based-pharmacokinetic-model","display_name":"physiologically based pharmacokinetic modeling","score":0.8379999995231628},{"id":"https://openalex.org/keywords/positron-emission-tomography","display_name":"positron emission tomography","score":0.7250000238418579},{"id":"https://openalex.org/keywords/89zr-radiolabeling","display_name":"89Zr radiolabeling","score":0.746999979019165},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.5989999771118164},{"id":"https://openalex.org/keywords/lymph-node-uptake","display_name":"lymph node uptake","score":0.6100000143051147},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.6740000247955322},{"id":"https://openalex.org/keywords/ct26-cells","display_name":"CT26 cells","score":0.6000000238418579},{"id":"https://openalex.org/keywords/rhesus-macaques","display_name":"rhesus monkeys","score":0.8289999961853027},{"id":"https://openalex.org/keywords/nonhuman-primates","display_name":"non-human primates","score":0.6480000019073486},{"id":"https://openalex.org/keywords/antibody-affinity","display_name":"antibody affinity","score":0.38199999928474426}],"concepts":[{"id":"https://openalex.org/C3017724952","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Pet imaging","level":3,"score":0.8705999851226807},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7692999839782715},{"id":"https://openalex.org/C185867374","wikidata":"https://www.wikidata.org/wiki/Q2562769","display_name":"Physiologically based pharmacokinetic modelling","level":3,"score":0.6779000163078308},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6574000120162964},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6089000105857849},{"id":"https://openalex.org/C136339569","wikidata":"https://www.wikidata.org/wiki/Q1142297","display_name":"Molecular imaging","level":3,"score":0.48559999465942383},{"id":"https://openalex.org/C2908856526","wikidata":"https://www.wikidata.org/wiki/Q16252627","display_name":"Antibody therapy","level":4,"score":0.4650000035762787},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4634000062942505},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.399399995803833},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.36039999127388},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.3384999930858612},{"id":"https://openalex.org/C92630104","wikidata":"https://www.wikidata.org/wiki/Q4115103","display_name":"Optical imaging","level":2,"score":0.31369999051094055},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.30320000648498535},{"id":"https://openalex.org/C128544194","wikidata":"https://www.wikidata.org/wiki/Q474859","display_name":"Translational research","level":2,"score":0.28209999203681946},{"id":"https://openalex.org/C2778172261","wikidata":"https://www.wikidata.org/wiki/Q3796563","display_name":"Imaging agent","level":3,"score":0.2799000144004822},{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.2676999866962433},{"id":"https://openalex.org/C3018913218","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody response","level":3,"score":0.25450000166893005},{"id":"https://openalex.org/C31601959","wikidata":"https://www.wikidata.org/wiki/Q931309","display_name":"Medical imaging","level":2,"score":0.25049999356269836}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0083","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0083","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0083","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A91.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0083","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0083","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0083","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A91.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.979200005531311}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W7225199932.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2954349576","https://openalex.org/W4249831286","https://openalex.org/W7136442368","https://openalex.org/W3104150772","https://openalex.org/W2994168084","https://openalex.org/W4224069656","https://openalex.org/W7146168584","https://openalex.org/W2995557603","https://openalex.org/W4389683935","https://openalex.org/W4416071286"],"abstract_inverted_index":{"Background":[0],"Limited":[1],"tumor":[2,30,96,136,154,163,275,300,356],"penetration":[3,31],"is":[4],"a":[5,88],"key":[6],"challenge":[7],"for":[8,128,277],"monoclonal":[9],"antibody":[10,20],"(MAb)":[11],"therapeutics":[12],"due":[13],"to":[14,57,60,69,130,134,151,250,281,359],"their":[15,365],"large":[16],"molecular":[17],"size.":[18],"Single-domain":[19],"fragments":[21],"(VHHs)":[22],"are":[23],"substantially":[24],"smaller":[25],"and":[26,32,41,51,72,87,111,116,139,148,193,224,230,302],"may":[27,352],"demonstrate":[28],"improved":[29,355],"accumulation.":[33],"To":[34],"evaluate":[35],"this":[36],"potential":[37],"advantage,":[38],"anti-CTLA-4":[39,205,306],"MAbs":[40,226,361],"VHHs":[42,351],"were":[43,67,91,118,143,195],"assessed":[44,119],"using":[45,145],"positron":[46],"emission":[47],"tomography":[48],"(PET)":[49],"imaging":[50,125,291],"physiologically":[52],"based":[53,265],"pharmacokinetic":[54],"(PBPK)":[55],"modeling":[56,264,295,348],"enable":[58],"translation":[59],"human":[61,153],"cancer":[62],"patients.Methods":[63],"All":[64],"evaluated":[65,92],"molecules":[66],"conjugated":[68],"p-SCN-Bn-Deferoxamine":[70],"(DFO)":[71],"radiolabeled":[73],"with":[74,166,185,254,293],"89Zr":[75],"(half-life":[76],"=":[77],"3.3":[78],"d).":[79],"In":[80,98,156,189,327],"mice,":[81,157],"an":[82,102,107,270,369],"anti-mouse":[83],"CTLA-4":[84,104,109,252,324],"MAb":[85,105,115,168,256,283,330],"(9D9-IgG2a)":[86],"corresponding":[89],"VHH":[90,159,206,215,249,279,315],"in":[93,120,274,288,316,341,362],"the":[94,158,167,204,213,248,255,278,282,314,329],"CT26":[95],"model.":[97],"non-human":[99],"primates":[100],"(NHPs),":[101],"anti-human":[103,108],"(ipilimumab),":[106],"VHH,":[110],"control":[112,214],"agents":[113],"(anti-RSV":[114],"VHH)":[117],"healthy":[121],"rhesus":[122,251],"monkeys.":[123],"PET":[124,267,290],"was":[126,207],"performed":[127],"up":[129],"9":[131],"days":[132],"post-administration":[133],"quantify":[135],"uptake,":[137],"biodistribution,":[138],"clearance.":[140,188],"PBPK":[141,263,294,347],"models":[142],"developed":[144],"PET-derived":[146],"tissue":[147,303,342],"blood":[149],"data":[150,268],"predict":[152],"exposure.Results":[155],"demonstrated":[160],"higher":[161,209,323],"initial":[162],"uptake":[164,202,312],"compared":[165,253],"(21.9":[169],"\u00b1":[170,174,217,221,228,232],"5.6":[171],"vs.":[172,219,259],"19.3":[173],"1.5":[175],"%ID/g),":[176],"but":[177],"exhibited":[178],"reduced":[179],"retention":[180],"over":[181],"7":[182],"days,":[183],"consistent":[184],"faster":[186],"systemic":[187,286],"NHPs,":[190],"overall":[191],"biodistribution":[192],"pharmacokinetics":[194],"comparable":[196,335],"across":[197],"agents.":[198],"However,":[199],"lymph":[200,310],"node":[201,311],"of":[203,212,247,299,305,313,334],"markedly":[208],"than":[210],"that":[211,350],"(7.2":[216],"2.2":[218,220,231],"0.4":[222,229],"SUV_max)":[223],"both":[225],"(2.1":[227],"0.2":[233],"SUV_max).":[234],"K":[235],"D":[236],"obtained":[237],"by":[238,322],"surface":[239],"plasmon":[240],"resonance":[241],"analysis":[242],"indicated":[243],"stronger":[244],"binding":[245,325],"affinity":[246],"(0.07":[257],"nM":[258],"1.8":[260],"nM).":[261],"Translational":[262,346],"on":[266],"predicted":[269],"approximately":[271],"1.5-fold":[272],"increase":[273],"exposure":[276,287,301,357],"relative":[280,358],"at":[284],"equivalent":[285],"humans.Conclusions":[289],"combined":[292],"enabled":[296],"quantitative":[297],"comparison":[298],"distribution":[304],"formats.":[307],"The":[308],"enhanced":[309],"NHPs":[317],"suggests":[318],"target-mediated":[319],"accumulation":[320],"driven":[321],"affinity.":[326,345],"contrast,":[328],"showed":[331],"limited":[332],"evidence":[333],"target":[336],"engagement,":[337],"potentially":[338],"reflecting":[339],"differences":[340],"accessibility":[343],"or":[344],"predicts":[349],"achieve":[353],"modestly":[354],"conventional":[360],"humans,":[363],"supporting":[364],"continued":[366],"evaluation":[367],"as":[368],"alternative":[370],"therapeutic":[371],"modality.":[372]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-04T00:00:00"}